Rivera, Alfredo Y.
HRN: 24-98-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
CEFTAZIDIME 1GM (VIAL)
05/12/2024
05/18/2024
IVTT
1g
Q8
Cap HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes